DD45721A - - Google Patents

Info

Publication number
DD45721A
DD45721A DD45721DA DD45721A DD 45721 A DD45721 A DD 45721A DD 45721D A DD45721D A DD 45721DA DD 45721 A DD45721 A DD 45721A
Authority
DD
German Democratic Republic
Application number
Publication of DD45721A publication Critical patent/DD45721A/xx

Links

DD45721D DD45721A (es)

Publications (1)

Publication Number Publication Date
DD45721A true DD45721A (es)

Family

ID=245756

Family Applications (1)

Application Number Title Priority Date Filing Date
DD45721D DD45721A (es)

Country Status (1)

Country Link
DD (1) DD45721A (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585796A (en) * 1982-08-10 1986-04-29 Hoffmann-La Roche Inc. Novel phenethanolamines
US4652679A (en) * 1982-05-14 1987-03-24 Hoffmann-La Roche Inc. Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity
US10288602B2 (en) 2013-01-08 2019-05-14 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatement

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652679A (en) * 1982-05-14 1987-03-24 Hoffmann-La Roche Inc. Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity
US4585796A (en) * 1982-08-10 1986-04-29 Hoffmann-La Roche Inc. Novel phenethanolamines
US10288602B2 (en) 2013-01-08 2019-05-14 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatement

Similar Documents

Publication Publication Date Title
CA1258454A (en) Phenethanolamines
US10288602B2 (en) Screening method, a kit, a method of treatment and a compound for use in a method of treatement
US4652679A (en) Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity
DD45721A (es)